Troponin I elevation after elective percutaneous coronary interventions: Prevalence and risk factors
| Autor: | Paula Maia, Lucia Helena Alvares Salis, Lucas Felipe Bastos Horta, Nelson Albuquerque de Souza e Silva, Roberto Muniz Ferreira |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Předmět: |
Male
medicine.medical_specialty Angiotensin receptor Stable angina Percutaneous RD1-811 medicine.medical_treatment Short Communication Coronary Artery Disease 030204 cardiovascular system & hematology Heart catheterization 03 medical and health sciences 0302 clinical medicine Percutaneous Coronary Intervention Postoperative Complications Risk Factors Angioplasty Internal medicine Troponin I medicine Prevalence Humans Diseases of the circulatory (Cardiovascular) system 030212 general & internal medicine Aged Coronary disease biology business.industry Angiotensin-converting enzyme Troponin Elective Surgical Procedures RC666-701 Conventional PCI biology.protein Cardiology Female Surgery business Cardiology and Cardiovascular Medicine Biomarkers Brazil |
| Zdroj: | Indian Heart Journal, Vol 69, Iss 3, Pp 322-324 (2017) |
| ISSN: | 0019-4832 |
| Popis: | Troponin elevation after coronary angioplasty is a prognostic marker associated with significant morbidity and mortality, although its prevalence varies according to clinical and procedural characteristics. We analyzed the frequency of post-procedural enzyme elevation among 112 elective interventions between 2013 and 2014 in a private hospital in Brazil. Troponin increase was observed in 62.5% of the procedures, and was related to age, female sex, low pre-procedural hemoglobin, prior angiotensin converting enzyme inhibitor or angiotensin receptor blocker use and multivessel angioplasty. PCI is not a risk free procedure and these results underscore the importance of a careful clinical assessment before its utilization. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|